The European Commission extended its antitrust review of the $111 billion Paramount-Warner Bros. Discovery merger from today's July 7 deadline to July 22, after Paramount submitted commitments on June 30 to exit its United International Pictures international distribution joint venture with Universal [1].

The paper's July 6 coverage tracked both the UIP exit as Paramount's operative concession to clear EU antitrust review and the correction to the California investigation posture — no court has frozen the deal; what exists is a multistate investigation, a consumer class action, and a motion to dismiss. Both readings carry into today's story, with the EU extension confirming the extended calendar the July 6 edition anticipated.

What July 6 did not fully name is the nearer clock. Alongside the standard antitrust review, the European Commission is conducting a parallel probe under the Foreign Subsidies Regulation, examining approximately $24 billion in Gulf sovereign wealth funding that backs the transaction — from Saudi Arabia's Public Investment Fund, Qatar's QIA, and Abu Dhabi's L'IMAD Holding [3]. That probe carries a July 14 deadline, one week before the antitrust review concludes on July 22. The deal faces two simultaneous European reviews before the end of the month, not one.

The FSR probe is structurally different from antitrust review. It does not evaluate whether the merger reduces competition; it evaluates whether foreign government subsidies distort the European market. The Gulf sovereign wealth stakes — which together would make the three funds' combined equity approximately 38.5 percent of the merged company — are not being reviewed as control positions; the deal was structured to give the Gulf investors non-voting equity, preserving control in the hands of David Ellison's family and RedBird Capital Partners [3]. Non-voting equity does not remove the FSR question, because the FSR focuses on whether the foreign subsidy distorted the bidding process, not on whether the foreign government exercises governance.

The antitrust remedy Paramount offered — exiting UIP — is relatively clean. UIP is a specific joint venture in a specific line of business; exiting it removes a named overlap with Universal's distribution operation, which the Commission identified as a competition concern. The Commission is described as "minded to clear" the deal on antitrust grounds following the concession, meaning it would proceed to unconditional clearance without a Phase II investigation [1].

The FSR outcome is less predictable. The Commission has used the Foreign Subsidies Regulation sparingly since it entered force in 2023, and the Paramount-Warner deal is one of the largest transactions subject to its scrutiny. The July 14 deadline could produce clearance, conditions, or an extension into Phase II. An extension into Phase II would run the Gulf-funding probe past the July 22 antitrust clearance date, creating a situation where one EU review clears and another remains open.

Beyond the EU, the merger faces a UK Competition and Markets Authority review with a current deadline of August 7, a California-led multistate attorney general investigation examining the deal's competitive and public-interest effects, and a consumer class action [2]. DOJ clearance — obtained earlier this year, without conditions — was the first regulatory approval, not the last word.

The deal's closing calendar now has three dates in rapid succession: July 14 (EU FSR probe), July 22 (EU antitrust), and August 7 (UK CMA). Any one of them can slip. An FSR extension past July 14, for instance, would leave the deal in a suspended state where the antitrust question is resolved but the foreign-subsidy question is not — and no closing can occur until both are.

The $111 billion transaction that entered this week as "in the home stretch" exits it with two European review deadlines running in parallel and a UK decision still pending.

-- THEO KAPLAN, San Francisco